Abstract PD3-07: Trastuzumab deruxtecan (T-DXd; DS-8201) with nivolumab in patients with HER2-expressing, advanced breast cancer: A 2-part, phase 1b, multicenter, open-label study
Keyword(s):
2017 ◽
Vol 49
(6)
◽
pp. 451
◽
Keyword(s):
2016 ◽
Vol 69
◽
pp. S11-S12
◽